SHAREHOLDERS’ AGREEMENT BETWEEN FONDS STRATEGIQUE D’INVESTISSEMENT Pierre-Henri BENHAMOU Bertrand DUPONT PHYS Participations and DBCS Participations IN THE PRESENCE OF DBV TECHNOLOGIES March 9, 2012Shareholders’ Agreement • September 22nd, 2014 • DBV Technologies S.A. • Biological products, (no disgnostic substances)
Fonds Stratégique d’Investissement, a limited company registered in the Trade and Companies Register of Paris under number 509 584 074, having its head office at 56, rue de Lille, 75007 Paris, represented by Thomas Devedjian and Maïlys Ferrère, duly authorized for the purposes hereof,
COMMERCIAL LEASECommercial Lease • September 22nd, 2014 • DBV Technologies S.A. • Biological products, (no disgnostic substances)
SELECTINVEST 1, a real estate investment trust with variable capital, with registered office in PARIS (75008) – 173, boulevard Haussmann, registered under number 784 852 261 R.C.S. [Registry of Trade and Companies] of PARIS.
